KORU Medical Systems, Inc. (KRMD)
USD 3.7
(-10.19%)
USD 3.7
(-10.19%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 28.51 Million USD | 2.23% |
| 2022 | 27.89 Million USD | 18.76% |
| 2021 | 23.49 Million USD | -2.84% |
| 2020 | 24.17 Million USD | 4.38% |
| 2019 | 23.16 Million USD | 33.47% |
| 2018 | 17.35 Million USD | 8.62% |
| 2017 | 15.97 Million USD | 29.96% |
| 2016 | 12.29 Million USD | 0.38% |
| 2015 | 12.24 Million USD | 8.92% |
| 2014 | 11.24 Million USD | 29.27% |
| 2013 | 8.69 Million USD | 12.04% |
| 2012 | 7.76 Million USD | 21.49% |
| 2011 | 6.39 Million USD | 29.87% |
| 2010 | 4.92 Million USD | 30.35% |
| 2009 | 3.77 Million USD | 9.76% |
| 2008 | 3.43 Million USD | 46.49% |
| 2007 | 2.34 Million USD | 35.35% |
| 2006 | 1.73 Million USD | -0.64% |
| 2005 | 1.74 Million USD | 11.89% |
| 2004 | 1.56 Million USD | 2.08% |
| 2003 | 1.52 Million USD | -7.74% |
| 2002 | 1.65 Million USD | -5.82% |
| 2001 | 1.75 Million USD | -15.68% |
| 2000 | 2.08 Million USD | 0.99% |
| 1999 | 2.06 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 8.43 Million USD | 2.83% |
| 2024 Q1 | 8.19 Million USD | 14.08% |
| 2023 FY | 28.51 Million USD | 2.23% |
| 2023 Q3 | 7 Million USD | 0.97% |
| 2023 Q2 | 6.93 Million USD | -6.18% |
| 2023 Q4 | 7.18 Million USD | 2.61% |
| 2023 Q1 | 7.39 Million USD | 0.65% |
| 2022 Q4 | 7.34 Million USD | -5.36% |
| 2022 Q2 | 6.54 Million USD | 4.84% |
| 2022 Q3 | 7.76 Million USD | 18.54% |
| 2022 Q1 | 6.24 Million USD | -3.79% |
| 2022 FY | 27.89 Million USD | 18.76% |
| 2021 FY | 23.49 Million USD | -2.84% |
| 2021 Q1 | 5.43 Million USD | 33.86% |
| 2021 Q2 | 5.52 Million USD | 1.79% |
| 2021 Q4 | 6.49 Million USD | 7.45% |
| 2021 Q3 | 6.04 Million USD | 9.27% |
| 2020 FY | 24.17 Million USD | 4.38% |
| 2020 Q3 | 6.08 Million USD | -21.13% |
| 2020 Q4 | 4.05 Million USD | -33.27% |
| 2020 Q1 | 6.33 Million USD | 1.73% |
| 2020 Q2 | 7.7 Million USD | 21.78% |
| 2019 Q4 | 6.22 Million USD | -5.97% |
| 2019 FY | 23.16 Million USD | 33.47% |
| 2019 Q3 | 6.61 Million USD | 23.72% |
| 2019 Q2 | 5.34 Million USD | 7.53% |
| 2019 Q1 | 4.97 Million USD | 16.47% |
| 2018 Q3 | 4.54 Million USD | 1.0% |
| 2018 FY | 17.35 Million USD | 8.62% |
| 2018 Q4 | 4.27 Million USD | -6.07% |
| 2018 Q1 | 4.03 Million USD | -13.44% |
| 2018 Q2 | 4.5 Million USD | 11.63% |
| 2017 Q4 | 4.65 Million USD | 21.05% |
| 2017 Q2 | 3.82 Million USD | 29.27% |
| 2017 Q1 | 2.96 Million USD | -7.22% |
| 2017 FY | 15.97 Million USD | 29.96% |
| 2017 Q3 | 3.84 Million USD | 0.52% |
| 2016 FY | 12.29 Million USD | 0.38% |
| 2016 Q1 | 3.3 Million USD | 5.11% |
| 2016 Q4 | 3.19 Million USD | 1.44% |
| 2016 Q3 | 3.14 Million USD | 5.28% |
| 2016 Q2 | 2.99 Million USD | -9.54% |
| 2015 Q4 | 3.14 Million USD | -0.67% |
| 2015 Q3 | 3.16 Million USD | 20.36% |
| 2015 Q2 | 2.63 Million USD | -23.7% |
| 2015 Q1 | 3.44 Million USD | 29.85% |
| 2015 FY | 12.24 Million USD | 8.92% |
| 2014 Q3 | 2.5 Million USD | -5.01% |
| 2014 Q4 | 2.65 Million USD | 6.0% |
| 2014 FY | 11.24 Million USD | 29.27% |
| 2014 Q1 | 2.63 Million USD | 20.86% |
| 2014 Q2 | 2.63 Million USD | 0.09% |
| 2013 Q4 | 2.17 Million USD | 8.56% |
| 2013 Q2 | 1.87 Million USD | -6.08% |
| 2013 FY | 8.69 Million USD | 12.04% |
| 2013 Q1 | 1.99 Million USD | -3.51% |
| 2013 Q3 | 2 Million USD | 7.01% |
| 2012 Q2 | 1.74 Million USD | -14.21% |
| 2012 Q4 | 2.07 Million USD | 6.09% |
| 2012 Q3 | 1.95 Million USD | 11.89% |
| 2012 FY | 7.76 Million USD | 21.49% |
| 2012 Q1 | 2.03 Million USD | 35.42% |
| 2011 FY | 6.39 Million USD | 29.87% |
| 2011 Q1 | 1.6 Million USD | 27.91% |
| 2011 Q2 | 1.49 Million USD | -6.87% |
| 2011 Q3 | 1.36 Million USD | -8.82% |
| 2011 Q4 | 1.5 Million USD | 10.21% |
| 2010 Q2 | 982.94 Thousand USD | -11.97% |
| 2010 FY | 4.92 Million USD | 30.35% |
| 2010 Q4 | 1.25 Million USD | 16.2% |
| 2010 Q1 | 1.11 Million USD | 24.33% |
| 2010 Q3 | 1.07 Million USD | 9.81% |
| 2009 Q4 | 898.1 Thousand USD | -5.17% |
| 2009 FY | 3.77 Million USD | 9.76% |
| 2009 Q1 | 949.04 Thousand USD | 11.18% |
| 2009 Q3 | 947.05 Thousand USD | 16.47% |
| 2009 Q2 | 813.12 Thousand USD | -14.32% |
| 2008 Q2 | 699.97 Thousand USD | -3.24% |
| 2008 Q1 | 723.43 Thousand USD | 16.52% |
| 2008 FY | 3.43 Million USD | 46.49% |
| 2008 Q4 | 853.59 Thousand USD | -8.85% |
| 2008 Q3 | 936.49 Thousand USD | 33.79% |
| 2007 FY | 2.34 Million USD | 35.35% |
| 2007 Q3 | 605.94 Thousand USD | 52.47% |
| 2007 Q4 | 620.87 Thousand USD | 2.46% |
| 2007 Q2 | 397.41 Thousand USD | -22.51% |
| 2007 Q1 | 512.85 Thousand USD | 11.98% |
| 2006 Q1 | 415.97 Thousand USD | -21.25% |
| 2006 Q3 | 416 Thousand USD | 19.64% |
| 2006 Q4 | 457.99 Thousand USD | 10.09% |
| 2006 FY | 1.73 Million USD | -0.64% |
| 2006 Q2 | 347.72 Thousand USD | -16.41% |
| 2005 Q2 | 382.3 Thousand USD | 9.5% |
| 2005 FY | 1.74 Million USD | 11.89% |
| 2005 Q4 | 528.19 Thousand USD | 25.96% |
| 2005 Q3 | 419.33 Thousand USD | 9.69% |
| 2005 Q1 | 349.12 Thousand USD | 3.56% |
| 2004 FY | 1.56 Million USD | 2.08% |
| 2004 Q2 | 507.47 Thousand USD | 49.69% |
| 2004 Q3 | 366.47 Thousand USD | -27.78% |
| 2004 Q4 | 337.14 Thousand USD | -8.0% |
| 2004 Q1 | 339.02 Thousand USD | -10.82% |
| 2003 Q1 | 387.92 Thousand USD | 1.67% |
| 2003 FY | 1.52 Million USD | -7.74% |
| 2003 Q4 | 380.16 Thousand USD | 0.12% |
| 2003 Q3 | 379.69 Thousand USD | -11.6% |
| 2003 Q2 | 429.5 Thousand USD | 10.72% |
| 2002 FY | 1.65 Million USD | -5.82% |
| 2002 Q4 | 381.54 Thousand USD | -15.56% |
| 2002 Q3 | 451.84 Thousand USD | 3.81% |
| 2002 Q2 | 435.24 Thousand USD | -4.75% |
| 2002 Q1 | 456.94 Thousand USD | 7.17% |
| 2001 Q1 | 556.57 Thousand USD | 27.66% |
| 2001 FY | 1.75 Million USD | -15.68% |
| 2001 Q4 | 426.39 Thousand USD | -4.85% |
| 2001 Q3 | 448.15 Thousand USD | 4.85% |
| 2001 Q2 | 427.41 Thousand USD | -23.21% |
| 2000 FY | 2.08 Million USD | 0.99% |
| 2000 Q2 | 556.61 Thousand USD | 0.0% |
| 2000 Q4 | 435.97 Thousand USD | -18.77% |
| 2000 Q3 | 536.74 Thousand USD | -3.57% |
| 1999 FY | 2.06 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 70.489% |
| AngioDynamics, Inc. | 303.91 Million USD | 90.617% |
| AtriCure, Inc. | 399.24 Million USD | 92.857% |
| Avinger, Inc. | 7.65 Million USD | -272.683% |
| Azenta, Inc. | 665.07 Million USD | 95.712% |
| BioLife Solutions, Inc. | 143.27 Million USD | 80.095% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 99.206% |
| Daxor Corporation | 1.28 Million USD | -2127.047% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -56.013% |
| Femasys Inc. | 1.07 Million USD | -2560.304% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 74.595% |
| Hologic, Inc. | 4.03 Billion USD | 99.292% |
| ICU Medical, Inc. | 2.25 Billion USD | 98.738% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.6% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 85.261% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -2374.463% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -2374.463% |
| Masimo Corporation | 2.04 Billion USD | 98.608% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 70.63% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 97.732% |
| Nephros, Inc. | 14.23 Million USD | -100.293% |
| NovoCure Limited | 509.33 Million USD | 94.401% |
| NEXGEL, Inc. | 4.08 Million USD | -597.424% |
| NEXGEL, Inc. | 4.08 Million USD | -597.424% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -879.652% |
| OraSure Technologies, Inc. | 405.47 Million USD | 92.967% |
| Pro-Dex, Inc. | 53.84 Million USD | 47.037% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -1502.032% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -49.273% |
| QuidelOrtho Corporation | 2.99 Billion USD | 99.049% |
| Repligen Corporation | 638.76 Million USD | 95.535% |
| Sanara MedTech Inc. | 64.98 Million USD | 56.12% |
| STAAR Surgical Company | 322.41 Million USD | 91.155% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | 43.219% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.281% |
| Jin Medical International Ltd. | 19.82 Million USD | -43.873% |